The present invention provides a Chinese medicine which can cause lung adenocarcinoma cell autophagy and is mainly based on polygala medicine. The quantity is decided by the doctor depending on the patients constitution and condition. The medicine may be taken as powder by grinding or by extraction, which can both cause the lung adenocarcinoma cell autophagy (lysis) to achieve the treatment effect. The polygala has been applied with new protein transport mode as target enzyme screening and successfully proved to have the efficacy of causing lung adenocarcinoma cell autophagy (lysis), so as to firmly achieve the cancer treatment effect and provide with the application progressiveness.一種可引發肺腺癌細胞自噬之中葯,系主要取遠志葯材為主,而經醫師視病人體質與病情所決定的份量,無論以研磨加工為粉末服用或以萃取方式服用,均可引發肺腺癌細胞自噬(裂解)效應,而達到治療效果;該遠志為應用新的蛋白轉運模式為目標酵素篩檢,成功證實具有引發肺腺癌細胞自噬(裂解)作用的功效,而能確實達到癌症治療效果,具使用進步性達成者。
